NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血栓症治療藥的全球市場:各藥物類別,各疾病類型,各流通管道的預測(到2025年)- COVID-19累積的影響

Thrombosis Drug Market Research Report by Drug Class, by Disease Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005127
出版日期 內容資訊 英文 195 Pages
商品交期: 最快1-2個工作天內
價格
血栓症治療藥的全球市場:各藥物類別,各疾病類型,各流通管道的預測(到2025年)- COVID-19累積的影響 Thrombosis Drug Market Research Report by Drug Class, by Disease Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 195 Pages
簡介

全球血栓症治療藥的市場規模預計將從2020年的246億2,942萬美元,擴大到2025年末的311億5,404萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

本報告提供全球血栓症治療藥市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,藥物類別·疾病類型·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各醫藥品分類市場展望
  • 各流通管道市場展望
  • 各疾病類型市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各藥物類別市場

  • 凝血因子Xa抑制劑
  • 肝素
  • P2Y12血小板抑制劑

第7章 各疾病類型市場

  • 心房纖維顫動
  • 深部靜脈血栓症
  • 肺動脈栓塞

第8章 各流通管道市場

  • 醫院藥局
  • 線上藥局
  • 零售藥局

第9章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業簡介

  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • AuroMedics Pharma LLC
  • Baxter International, Inc.
  • Bayer AG
  • Biogen Inc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • DAIICHI SANKYO COMPANY, LIMITED.
  • GlaxoSmithKline plc
  • GoodRx, Inc.
  • Grifols, S.A
  • Inari Medical, Inc.
  • ITALFARMACO S.p.A
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Mylan N.V.
  • Pfizer, Inc
  • Sanofi
  • Vasudha Pharma

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-030298DFFFC9

The Global Thrombosis Drug Market size was estimated at USD 24.62 Billion in 2020 and expected to reach USD 25.93 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.65% to reach USD 34.25 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Thrombosis Drug to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Class, the Thrombosis Drug Market was studied across Factor Xa Inhibitor, Heparin, and P2Y12 Platelet Inhibitor.

Based on Disease Type, the Thrombosis Drug Market was studied across Atrial Fibrillation, Deep Vein Thrombosis, and Pulmonary Embolism.

Based on Distribution Channel, the Thrombosis Drug Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Geography, the Thrombosis Drug Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Thrombosis Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Thrombosis Drug Market, including Aspen Pharmacare Holdings Limited, AstraZeneca PLC, AuroMedics Pharma LLC, Baxter International, Inc., Bayer AG, Biogen Inc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, DAIICHI SANKYO COMPANY, LIMITED., GlaxoSmithKline plc, GoodRx, Inc., Grifols, S.A, Inari Medical, Inc., ITALFARMACO S.p.A, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Mylan N.V., Pfizer, Inc, Sanofi, and Vasudha Pharma.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Thrombosis Drug Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Thrombosis Drug Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Thrombosis Drug Market?
  • 4. What is the competitive strategic window for opportunities in the Global Thrombosis Drug Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Thrombosis Drug Market?
  • 6. What is the market share of the leading vendors in the Global Thrombosis Drug Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Thrombosis Drug Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Class Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Disease Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Poor eating habits and sedentary lifestyle among consumers
      • 5.1.1.2. Rising cases of cardiovascular diseases
      • 5.1.1.3. Increasing geriatric and obese population
      • 5.1.1.4. Recent advances in hematology
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects risk associated with thrombosis drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Government awareness programs and support for healthcare improvements
      • 5.1.3.2. Advanced therapeutic strategies for thrombosis
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness regarding thromboembolism conditions
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Thrombosis Drug Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Factor Xa Inhibitor
  • 6.3. Heparin
  • 6.4. P2Y12 Platelet Inhibitor

7. Thrombosis Drug Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation
  • 7.3. Deep Vein Thrombosis
  • 7.4. Pulmonary Embolism

8. Thrombosis Drug Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Thrombosis Drug Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Thrombosis Drug Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Thrombosis Drug Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Aspen Pharmacare Holdings Limited
  • 13.2. AstraZeneca PLC
  • 13.3. AuroMedics Pharma LLC
  • 13.4. Baxter International, Inc.
  • 13.5. Bayer AG
  • 13.6. Biogen Inc
  • 13.7. Boehringer Ingelheim GmbH
  • 13.8. Bristol-Myers Squibb
  • 13.9. DAIICHI SANKYO COMPANY, LIMITED.
  • 13.10. GlaxoSmithKline plc
  • 13.11. GoodRx, Inc.
  • 13.12. Grifols, S.A
  • 13.13. Inari Medical, Inc.
  • 13.14. ITALFARMACO S.p.A
  • 13.15. Janssen Pharmaceuticals, Inc.
  • 13.16. Johnson & Johnson
  • 13.17. Mylan N.V.
  • 13.18. Pfizer, Inc
  • 13.19. Sanofi
  • 13.20. Vasudha Pharma

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBOSIS DRUG MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL THROMBOSIS DRUG MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL THROMBOSIS DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 11. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY FACTOR XA INHIBITOR, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY FACTOR XA INHIBITOR, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HEPARIN, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY P2Y12 PLATELET INHIBITOR, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY P2Y12 PLATELET INHIBITOR, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2026
  • FIGURE 20. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ATRIAL FIBRILLATION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY PULMONARY EMBOLISM, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 29. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. CANADA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. MEXICO THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. CALIFORNIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. FLORIDA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. ILLINOIS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. NEW YORK THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. OHIO THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. PENNSYLVANIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. TEXAS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. INDIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. JAPAN THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. THAILAND THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. GERMANY THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. ITALY THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. QATAR THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SPAIN THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. GLOBAL THROMBOSIS DRUG MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL THROMBOSIS DRUG MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL THROMBOSIS DRUG MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL THROMBOSIS DRUG MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL THROMBOSIS DRUG MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY FACTOR XA INHIBITOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY P2Y12 PLATELET INHIBITOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ATRIAL FIBRILLATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY PULMONARY EMBOLISM, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CANADA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CANADA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CANADA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. CALIFORNIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. CALIFORNIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CALIFORNIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. FLORIDA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. FLORIDA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. FLORIDA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ILLINOIS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ILLINOIS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ILLINOIS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. NEW YORK THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. NEW YORK THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. NEW YORK THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. OHIO THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. OHIO THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. OHIO THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. PENNSYLVANIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. PENNSYLVANIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PENNSYLVANIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. TEXAS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. TEXAS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. TEXAS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. CHINA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. CHINA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CHINA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. INDIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. INDIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. INDIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. ITALY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. ITALY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. QATAR THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. QATAR THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. QATAR THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. GLOBAL THROMBOSIS DRUG MARKET: SCORES
  • TABLE 122. GLOBAL THROMBOSIS DRUG MARKET: BUSINESS STRATEGY
  • TABLE 123. GLOBAL THROMBOSIS DRUG MARKET: PRODUCT SATISFACTION
  • TABLE 124. GLOBAL THROMBOSIS DRUG MARKET: RANKING
  • TABLE 125. GLOBAL THROMBOSIS DRUG MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 126. GLOBAL THROMBOSIS DRUG MARKET: SHARE, BY COMPANY, 2020
  • TABLE 127. GLOBAL THROMBOSIS DRUG MARKET: MERGER & ACQUISITION
  • TABLE 128. GLOBAL THROMBOSIS DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 129. GLOBAL THROMBOSIS DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 130. GLOBAL THROMBOSIS DRUG MARKET: INVESTMENT & FUNDING
  • TABLE 131. GLOBAL THROMBOSIS DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 132. GLOBAL THROMBOSIS DRUG MARKET: LICENSE & PRICING
  • TABLE 133. GLOBAL THROMBOSIS DRUG MARKET: CONTACT DETAILS